Protéus delivers a significant technology milestone for biofuel application to Syngenta
Nîmes, France – September 19, 2011 - Protéus, the French industrial biotechnology company and a member of the PCAS group, today announced the delivery of a significant technology milestone to Syngenta, a world-leading agribusiness company committed to sustainable agriculture through innovative research and technology. Within this 2009-initiated relationship, Protéus successfully completed enzyme optimization for developing high performance crops for biofuel applications. Improved variants were transferred to Syngenta for further development and industrialization.
“We are proud of having provided the contribution of our technologies and know-how related to biodiversity and protein engineering to a leader in crop protection, and one of the key-players in the high–value commercial seeds market” explains Gilles Ravot, Protéus’ President and CEO. “With Syngenta, we innovate to deliver game-changing technologies which will enhance productivity in the global biofuels industry.”
Protéus benefits from a unique collection of natural microbial biodiversity that has been built in collaboration with world leading experts. This biodiversity is one of the company’s treasures, opening access to innovative products with unprecedented, hence patentable capabilities.
Since 1998, Protéus has been recognized as a leader in the development and optimization of bioproducts and bioprocesses for industry. Key success factors include an international network of corporate and academic partners that the Company has built and maintained since inception, and a comprehensive set of powerful tools such as the proprietary L-Shuffling™ and EvoSight™ directed evolution technologies.
About Protéus, a member of the PCAS Group
Protéus (www.proteus.fr) is a biotechnology company specialized in the design, development and implementation of sustainable industrial processes using e.g. enzymes and microbial strains. To fulfill this mission, Protéus benefits from a portfolio of proprietary technologies including a collection of exclusive microbial biodiversity, technologies for enzymes engineering and microbial strains optimization, and a platform of enzyme production and formulation to turn them into industrial tools. A member of the chemical Group PCAS, Protéus also benefits from the industrial capabilities and expertise of the Group. The PCAS Group (www.pcas.com) is a fine and specialty chemicals Group which shares an ambition for excellence with its customers, which primarily include market-leading international groups. PCAS designs and delivers the best industrial solutions for its customers' specific expectations. These various expectations all share a common demand for safety, quality, competi